131311-25-6
131311-25-6
Chemical Structure
TCV-309
- CAS No.: 131311-25-6
- Formula:C30H34BrN5O7
- Molecular Weight:656.52
IUPAC Name: 3-bromo-5-((3-oxo-3-((2-((1,2,3,4-tetrahydroisoquinoline-2-carbonyl)oxy)ethyl)amino)propyl)(phenyl)carbamoyl)-1-propylpyridin-1-ium nitrate
InChIKey: DVGLBKDNVHDMTD-UHFFFAOYSA-O
SMILES: CCC[N+]1=CC(C(N(CCC(NCCOC(N2CC3=C(C=CC=C3)CC2)=O)=O)C4=CC=CC=C4)=O)=CC(Br)=C1.[O-][N+]([O-])=O
Biological Activity: TCV-309 is an antagonist for platelet activating factor (PAF). TCV-309 improves the left ventricular function during ischemia-reperfusion (77.6% recover at 1 μM), protects the cardiac function[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TCV-309 | TCV-309 is an antagonist for platelet activating factor (PAF). TCV-309 improves the left ventricular function during ischemia-reperfusion (77.6% recover at 1 μM), protects the cardiac function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
